Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure

European Heart Journal

Volumn 27, Issue 23, 2006, Pages 2866-2870

  Pedersen, Ole Dyg ^a   Søndergaard, Peter ^b   Nielsen, Tonny ^c   Nielsen, Søren Junge ^d   Nielsen, Eric Steen ^e   Falstie Jensen, Niels ^f   Nielsen, Ingolf ^g   Køber, Lars ^h   Burchardt, Hans ^g   Seibæk, Marie ⁱ   Torp Pedersen, Christian ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c University of Esbjerg   (Denmark)

^d FREDERIKSBERG HOSPITAL   (Denmark)

^e VIBORG HOSPITAL   (Denmark)

^f NORTH DENMARK REGIONAL HOSPITAL   (Denmark)

^g ROSKILDE HOSPITAL   (Denmark)

^h Rigshospitalet   (Denmark)

ⁱ GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Atrial fibrillation; Congestive heart failure; Ischaemic heart disease; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DENMARK; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 33845346805     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl359     Document Type: Article

References (22)

1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
2. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. The occurrence and prognostic significance of atrial fibrillation/flutter following acute myocardial infarction. TRACE (TRAndolapril Cardiac Evaluation) Study group. Eur Heart J 1999;20:748-754.
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-952.
4. Pedersen OD, Brendorp B, Kober L, Torp-Pedersen C. Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study. Congest Heart Fail 2003;9:333-340.
5. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials. J Am Coll Cardiol 1998;32:695-703.
6. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991;84:40-48.
7. Mathew J, Hunsberger S, Fleg J, Mc Sherry F, Williford W, Yusuf S. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest 2000;118:914-922.
8. Maggioni A, Gorini M, Midi P, Lussi D, Tavazzi L; on behalf of the IN-CHF investigators. Predictors of 1-year mortality in 2086 outpatients with congestive heart failure: data from the Italian network on congestive heart failure. J Am Coll Cardiol 1998;34(Suppl. A):218A.
9. Lengyel M, Kokeny M. Follow-up study in congestive (dilated) cardiomyopathy. Acta Cardiol 1981;36:35-48.
10. Hofmann T, Meinertz T, Kasper W, Geibel A, Zehender M, Hohnloser S, Stienen U, Treese N, Just H. Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J 1988;116:1455-1463.
11. Maggioni AP, Latini R, Carson PE, Singh SN, Barlera S, Glazer R, Masson S, Cere E, Tognoni G, Cohn JN. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J 2005;149:548-557.
12. Diaz RA, Obasohan A, Oakley CM. Prediction of outcome in dilated cardiomyopathy. Br Heart J 1987;58:393-399.
13. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981;47:525-531.
14. Juilliere Y, Danchin N, Briancon S, Khalife K, Ethevenot G, Balaud A, Gilgenkrantz JM, Pernot C, Cherrier F. Dilated cardiomyopathy: long-term follow-up and predictors of survival. Int J Cardiol 1988;21:269-277.
15. Keogh AM, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or ischaemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990;65:903-908.
16. Koide T, Kato A, Takabatake Y, Iizuka M, Uchida Y, Ozeki K, Morooka S, Makihana M, Serizawa T, Tanaka S, Ohya T, Momomura S, Murao S. Variable prognosis in congestive cardiomyopathy. Role of left ventricular function, alcoholism, and pulmonary thrombosis. Jpn Heart J 1980;21:451-463.
17. Romeo F, Pelliccia F, Cianfrocca C, Cristofani R, Reale A. Predictors of sudden death in idiopathic dilated cardiomyopathy. Am J Cardiol 1989;63:138-140.
18. Crijns HJ, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, van den Berg MP, van Veldhuisen DJ. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 2000;21:1238-1245.
19. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(Suppl. 6):VI102-VI110.
20. Convert G, Delaye J, Beaune J, Biron A, Gonin A. Prognosis of primary non-obstructive cardiomyopathies. Arch Mal Coeur Vaiss 1980;73:227-237.
21. Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, Komajda M, Metra M, Torp-Pedersen C, Poole-Wilson P. Prognostic relevance of atrial ibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 2005;26:1303-1308.
22. Torp-Pedersen C, Moller M, Bloch-Thomsen PE, Kober L, Sandoe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm AJ. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999;341:857-865.